6-K XBRL

FORM 6-K

Company: Galmed Pharmaceuticals Ltd.
Filed: July 31, 2017
Period of Report: July 31, 2017
Accession Number: 0001144204-17-039116

View Document ↗ View on SEC.gov ↗